跳至主要内容
临床试验/NCT02074423
NCT02074423已完成不适用

A Randomized, Controlled, Double-blind, Cross-over Clinical Trial, Evaluating the Effect of MealShape™ on the Postprandial Glycemia After Eating Standard Food, in Healthy Volunteers.

Dialpha2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
2
主要终点
Blood glucose incremental Area Under the Curve between 0 and 120 minutes after consumption of a standard meal, compared between MealShape and the placebo

研究概览

简要总结

The purpose of the study is to evaluate the effect of MealShape, a Ceylon cinnamon extract (Cinnamomum zeylanicum) on blood glucose and insulin response after consumption of a standard meal composed of white bread, in healthy male and female volunteers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male and female volunteers, able to read and write, aged from 18 to 45 years inclusive at time of screening
  • Good physical condition
  • Body Mass Index (BMI) ≥ 18,5 and < 25 kg/m²
  • Written informed consent provided prior to screening, after receiving and understanding the subject information
  • Stable body weight (< 5% variation) within the last 3 months prior to screening.
  • Subject accepting to keep the same lifestyle throughout the study regarding physical activity, no smoking etc.
  • Registered with the French Social Security, in agreement with the French law on biomedical experimentation.

排除标准

  • Subject with type 1 or 2 diabetes
  • Smoker. Light smoker (less than 5 cigarettes per day) or former smoker (smoking more than 5 cigarettes per day) having stopped less than three months. Smoking (or use of smoking substitute e.g. nicotine patch) is not permitted from screening throughout the study.
  • Subject with fasting capillary blood glucose level > 110 mg/dl.
  • Subject with fasting capillary blood glucose level ≤ 110 mg/dl and 2 hours postprandial capillary blood glucose level > 140 mg/dl during an Oral Glucose Tolerance Test.
  • Subject with any sensitivity or allergy to any of the products used within this clinical trial.
  • Intake of product (food and dietary supplement) having an effect on glycemia and insulinemia.
  • Intake of all chronic medication excepted oestroprogestative or progestative contraception started at least three months preceding the screening visit.

结局指标

主要结局

Blood glucose incremental Area Under the Curve between 0 and 120 minutes after consumption of a standard meal, compared between MealShape and the placebo

时间窗: Over 120 minutes after the consumption of a standard meal

次要结局

  • Blood glucose incremental Area Under the Curve between 0 and 60 minutes compared between MealShape and the placebo after consumption of a standard meal,(Over 60 minutes after consumption of a standard meal)
  • Capillary blood glucose maximal concentration between MealShape and Placebo after consumption of a standard meal(Over 120 minutes after consumption of a standard meal)
  • Comparison of glycemia values between MealShape and Placebo at the following time points: T0, T15, T30, T45, T60, T90 and T120 minutes after consumption of a standard meal(Over 120 minutes after consumption of a standard meal)
  • Evaluation of the safety of MealShape with adverse events recording(3 weeks)
  • Insulin incremental Area under the Curve between 0 and 60 minutes compared between MealShape and Placebo after consumption of a standard meal(Over 60 minutes after connsumption of a standard meal)
  • Insulin incremental Area under the Curve between 0 and 120 minutes compared between MealShape and Placebo after consumption of a standard meal(Over 120 minutes after consumption of a standard meal)

研究者

发起方
Dialpha
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验